Literature DB >> 25537428

Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas.

Yukihiko Sonoda1, Ichiyoo Shibahara, Tomohiro Kawaguchi, Ryuta Saito, Masayuki Kanamori, Mika Watanabe, Hiroyoshi Suzuki, Toshihiro Kumabe, Teiji Tominaga.   

Abstract

The aim of this study was to determine if molecular alterations are associated with tumor location and radiological characteristics in anaplastic gliomas. We performed a retrospective analysis of 122 anaplastic gliomas for molecular alterations (IDH1/2 mutations, TP53 mutations, and 1p19q co-deletion) to compare MRI features (location and image characteristics). We observed that IDH mutation is strongly associated with frontal location (P = 0.001). However, 13 tumors not located in the cerebral cortex were IDH intact tumors (P < 0.0001). While IDH mutation and TP53 mutation are significantly associated with AA (p < 0.0001), IDH mutation and 1p19q co-deletion were significantly associated with AO/AOA (p < 0.0001). No tumors with IDH mutation and 1p19q co-deletion infiltrated the temporal lobe (P = 0.003). The tumors with 1p19q co-deletion and histologically diagnosed as AO/AOA were associated with contrast enhancement on MR images (p = 0.007, p = 0.002, respectively) and those with TP53 mutation had a weak association with sharp tumor borders (p = 0.043). MRI features might be useful to predict molecular profiles in anaplastic gliomas.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25537428     DOI: 10.1007/s10014-014-0211-3

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.154


  22 in total

1.  Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.

Authors:  Shanshan Jiang; Tianyu Zou; Charles G Eberhart; Maria A V Villalobos; Hye-Young Heo; Yi Zhang; Yu Wang; Xianlong Wang; Hao Yu; Yongxing Du; Peter C M van Zijl; Zhibo Wen; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2017-07-16       Impact factor: 4.668

2.  Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.

Authors:  Tomohiro Kawaguchi; Yukihiko Sonoda; Ichiyo Shibahara; Ryuta Saito; Masayuki Kanamori; Toshihiro Kumabe; Teiji Tominaga
Journal:  J Neurooncol       Date:  2016-07-11       Impact factor: 4.130

3.  Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic review.

Authors:  Arian Lasocki; Mustafa Anjari; Suna Ӧrs Kokurcan; Stefanie C Thust
Journal:  Neuroradiology       Date:  2020-08-25       Impact factor: 2.804

4.  The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma.

Authors:  Ryan S Youland; Cole R Kreofsky; David A Schomas; Paul D Brown; Jan C Buckner; Nadia N Laack
Journal:  J Neurooncol       Date:  2017-08-23       Impact factor: 4.130

5.  Contrast enhancement predicting survival in integrated molecular subtypes of diffuse glioma: an observational cohort study.

Authors:  Johann-Martin Hempel; Cornelia Brendle; Benjamin Bender; Georg Bier; Marco Skardelly; Irina Gepfner-Tuma; Franziska Eckert; Ulrike Ernemann; Jens Schittenhelm
Journal:  J Neurooncol       Date:  2018-04-17       Impact factor: 4.130

Review 6.  Can artificial intelligence overtake human intelligence on the bumpy road towards glioma therapy?

Authors:  Precilla S Daisy; T S Anitha
Journal:  Med Oncol       Date:  2021-04-03       Impact factor: 3.064

7.  Machine learning-based quantitative texture analysis of conventional MRI combined with ADC maps for assessment of IDH1 mutation in high-grade gliomas.

Authors:  Deniz Alis; Omer Bagcilar; Yeseren Deniz Senli; Mert Yergin; Cihan Isler; Naci Kocer; Civan Islak; Osman Kizilkilic
Journal:  Jpn J Radiol       Date:  2019-11-18       Impact factor: 2.374

Review 8.  Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma.

Authors:  Fabrício Guimarães Gonçalves; Sanjeev Chawla; Suyash Mohan
Journal:  J Magn Reson Imaging       Date:  2020-03-19       Impact factor: 4.813

9.  Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis.

Authors:  Chong Hyun Suh; Ho Sung Kim; Seung Chai Jung; Choong Gon Choi; Sang Joon Kim
Journal:  Eur Radiol       Date:  2018-07-12       Impact factor: 5.315

10.  Multivariable non-invasive association of isocitrate dehydrogenase mutational status in World Health Organization grade II and III gliomas with advanced magnetic resonance imaging T2 mapping techniques.

Authors:  Maike Kern; Timo A Auer; Uli Fehrenbach; Yasemin Tanyildizi; Thomas Picht; Martin Misch; Edzard Wiener
Journal:  Neuroradiol J       Date:  2020-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.